Immune Checkpoint Inhibitor-Associated Type 1 Diabetes Mellitus: Case Series, Review of the Literature, and Optimal Management

With the introduction of immune checkpoint inhibitors into clinical practice, various autoimmune toxicities have been described. Antibodies targeting the receptor:ligand pairing of programmed death receptor-1 (PD-1) and its cognate ligand programmed death-ligand 1 (PD-L1) in rare reports have been a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapke, Jonathan, Shaheen, Zachary, Kilari, Deepak, Knudson, Paul, Wong, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731100/
https://www.ncbi.nlm.nih.gov/pubmed/29279690
http://dx.doi.org/10.1159/000480634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731100/
https://www.ncbi.nlm.nih.gov/pubmed/29279690
http://dx.doi.org/10.1159/000480634

Ejemplares similares